The FDA uses therapeutic equivalence codes to determine which generic drugs can safely replace brand-name medications. Learn how A and B codes work, why some generics aren't interchangeable, and how pharmacists use the Orange Book to ensure safe substitutions.
Learn how online pharmacy counseling helps you find affordable generic medication alternatives. Expert guide on platforms, safety, costs, and benefits.
A clear guide that breaks down FDA risk‑benefit statements, shows where they appear, how to read numbers, and tips for patients to make informed decisions.
Affirmative consent laws don't apply to medical decisions. Learn how real patient permission works through informed consent and substituted judgment when you can't speak for yourself.
In my latest blog post, I discussed the crucial role of cycloserine in managing multidrug-resistant tuberculosis (MDR-TB). Cycloserine, an antibiotic, has become increasingly important in the treatment of MDR-TB, especially when other first-line medications are ineffective. This is because it targets the bacteria causing TB in a different way, thus overcoming resistance. However, it's essential to use cycloserine in combination with other antibiotics to ensure maximum effectiveness and minimize the risk of further resistance. Overall, cycloserine plays a vital role in the fight against MDR-TB, and ongoing research is crucial to optimize its use and develop new treatments.
State laws determine whether pharmacists must or can switch your brand-name prescription to a cheaper generic. These rules affect your costs, safety, and access-and vary widely across the U.S.